PekCura Labs sells SLU-PP-332 10mL 2mg/mL (CAS 303760-60-3) directly to laboratories and research facilities across the USA, with 99 percent or higher purity confirmed by independent third-party testing
Patch testing is recommended before initiating treatment, especially for patients with histories of metal sensitivities
Practically, this means that a Glow Stack vial in a research workspace is an in vitro and animal-model reagent
Our human SMC contractility model is designed to bring clarity where it matters: Real-time monitoring of vascular tone Quantification of contractile responses Mechanistic understanding of compound effects Based on impedance measurements, the model captures dynamic changes in cell morphology and cytoskeleton, directly linked to contractility What this means for your R&D: Earlier detection of vasoactive effects Better ranking of compounds More confident decisions before moving to in vivo Because better data early means fewer surprises later
The majority of the data remain preclinical
Disulphide bond integrity: Uniquely important for this compound, the disulphide bond between Cys-7 and Cys-15 must be correctly formed
